Navigation path

HOME
Policy areas
Sectors
About competition policy
Cases & legislation
Current Issues
Contacts
In this section:
Overview
What's new?
Cases >
Documents
Sector inquiry

Pharmaceuticals

What's new?

10.12.2013 Antitrust: Commission fines Johnson & Johnson and Novartis € 16 million for delaying market entry of generic pain-killer fentanyl
09.12.2013 Antitrust: Commission welcomes continued low level of potentially problematic patent settlements in EU pharma sector
04.12.2013 State aid: Commission approves aid for innovative medical services in remote areas of Saxony
24.07.2013 State aid: Commission opens in-depth inquiry into alleged aid to German pharmaceutical companies in financial difficulties
19.06.2013 Antitrust: Commission fines Lundbeck and other pharma companies for delaying market entry of generic medicines
31.01.2013 Antitrust: Commission sends Statement of Objections to J&J and Novartis on delayed entry of generic pain-killer
06.12.2012 Antitrust: Commission welcomes Court of Justice judgment in the AstraZeneca case
12.11.2012 Mergers: Commission approves acquisition of Teva's over the counter business by Procter & Gamble
05.10.2012 Mergers: Commission approves acquisition of pharma company Actavis by rival Watson
08.08.2012 Mergers: Commission approves acquisition of medical device company BSN Medical by Guernsey based investment fund EQT VI
30.07.2012 Antitrust: Commission sends Statement of Objections on perindopril to Servier and others
25.07.2012 State aid: Commission enforcement action in pharmaceutical sector following sector inquiry
25.07.2012 Commission sends Statement of Objections to Lundbeck and others for preventing market entry of generic antidepressant medicine
08.05.2012 State aid: Commission launches major initiative to modernise state aid control
08.05.2012 State aid: the Commission clears 23 million EUR R&D aid to Novartis Italy for faster access to innovative vaccines in developing countries
19.04.2012 Mergers: Commission approves acquisition of medical device company Synthes by Johnson & Johnson
18.04.2012 Mergers: Commission approves acquisition of Air Products Homecare by Linde
30.03.2012 Competition policy for the post-crisis era
01.03.2012 Antitrust: Commission closes investigation in pharmaceutical companies AstraZeneca and Nycomed
10.02.2012 Mergers: Commission approves acquisition of Teeuwissen, Quintet, Jagero II and Bioiberica by Saria in the food and pharmaceutical sectors
27.01.2012 Antitrust: Commission closes procedural case against Servier
15.12.2011 Mergers: Commission approves acquisition of Belgian health company Omega Pharma by private equity fund manager Waterland and Belgian Alychlo
21.10.2011 Antitrust: Commission opens proceedings against Johnson & Johnson and Novartis
07.07.2011 Mergers: Commission approves acquisition of Janssen Animal Health by pharmaceutical group Eli Lilly
10.06.2011 Mergers: Commission approves acquisition of Ferrosan's Consumer Health Care Business by Pfizer
19.05.2011 Mergers: Commission clears proposed joint venture between Dutch pharma company DSM and Sinochem
28.04.2011 Antitrust: Commission opens investigation against pharmaceutical companies Cephalon and Teva
21.02.2011 Commission clears acquisition of joint control over Actamax by DSM and DuPont
17.01.2011 Antitrust: Commission launches second monitoring exercise of patent settlements in pharma sector
12.01.2011 Mergers: Commission clears proposed acquisition of Genzyme by Sanofi-Aventis






  
  
Related links
Antitrust: latest case documents (all sectors)
Mergers: latest case documents (all sectors)
State Aid: latest case documents (all sectors)